Owens & Minor (NYSE:OMI) Releases FY 2025 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.600-1.850 for the period, compared to the consensus estimate of 1.740. The company issued revenue guidance of $10.9 billion-$11.2 billion, compared to the consensus revenue estimate of $11.0 billion.

Analysts Set New Price Targets

Several analysts have weighed in on OMI shares. Robert W. Baird upped their price objective on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. Citigroup dropped their target price on shares of Owens & Minor from $13.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, April 17th. JPMorgan Chase & Co. decreased their price target on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a research note on Monday, March 10th. Finally, UBS Group lowered their price target on Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $12.50.

Owens & Minor Stock Up 0.1 %

Shares of NYSE OMI opened at $7.72 on Thursday. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The company has a 50-day moving average price of $8.23 and a 200-day moving average price of $10.90. The stock has a market capitalization of $596.41 million, a P/E ratio of -11.88, a P/E/G ratio of 0.20 and a beta of 1.38. Owens & Minor has a 1 year low of $6.07 and a 1 year high of $21.02.

Owens & Minor (NYSE:OMI) last posted its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.03. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. On average, equities research analysts forecast that Owens & Minor will post 1.51 EPS for the current fiscal year.

Owens & Minor announced that its Board of Directors has initiated a stock repurchase plan on Friday, February 28th that allows the company to buyback $100.00 million in shares. This buyback authorization allows the company to purchase up to 13.6% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s board of directors believes its stock is undervalued.

Insider Transactions at Owens & Minor

In other Owens & Minor news, major shareholder Coliseum Capital Management, L purchased 225,000 shares of the stock in a transaction dated Wednesday, April 9th. The shares were bought at an average price of $7.39 per share, with a total value of $1,662,750.00. Following the completion of the transaction, the insider now directly owns 11,482,955 shares in the company, valued at approximately $84,859,037.45. This trade represents a 2.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have acquired 2,718,412 shares of company stock worth $24,495,308 in the last ninety days. Company insiders own 3.69% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.